Heart-type Fatty Acid Binding Protein Assay Kit is suitable for routine laboratory use

The Heart-type Fatty Acid Binding Protein (H-FABP) Assay Kit is an essential tool designed for the quantitative determination of H-FABP levels in human serum. This in vitro diagnostic kit plays a crucial role in the auxiliary diagnosis of various myocardial injuries, including acute myocardial infarction (AMI). H-FABP is a protein released by cardiac myocytes during injury, making its measurement significant for assessing cardiac health.

The clinical importance of H-FABP lies in its early diagnostic capability for AMI, allowing healthcare providers to identify myocardial damage promptly. By evaluating the concentration of H-FABP in serum, clinicians can gain insights into the severity of myocardial infarction and the extent of early myocardial injury. Furthermore, this assay assists in the assessment of myocardial ischemia and reperfusion, providing valuable data for patient management. Elevated levels of H-FABP can indicate poor prognosis in patients with cardiac failure, highlighting the need for timely and accurate testing.

This kit is composed of two reagents, each available in specifications of 60 x 2, 100 x 1, and 25 x 1, ensuring flexibility and convenience for various testing scenarios. The packaging options, including 7170, 7060, TBA 120FR, TBA 2000FR, and TBA 40FR, are designed to accommodate different laboratory needs and ensure safe storage and handling of the reagents.

The use of this assay kit enhances the diagnostic process by allowing for rapid and reliable results. Its straightforward application makes it suitable for routine laboratory use, aiding in the early detection of acute myocardial conditions. Overall, the H-FABP Assay Kit is a vital component in the toolkit for cardiologists and medical laboratories, supporting improved patient outcomes through early intervention and tailored treatment plans. By integrating this assay into clinical practice, healthcare providers can effectively monitor cardiac health, leading to timely diagnoses and better management of heart-related ailments.